This is an open-label, proof of concept trial to investigate the efficacy, safety and
tolerability of Zulresso (brexanolone) administered to adult female subjects diagnosed with
postpartum psychosis. This study will provide critical pilot data to determine whether there
is similar treatment efficacy among patients with postpartum psychosis as observed to date in
patients with postpartum depression.